Browsing by Advisor "Abdool Karim, Quarraisha."

Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire.

Scheepers, Cathrine.; Shrestha, Ram K.; Lambson, Bronwen Elizabeth.; Jackson, Katherine J. L.; Wright, Imogen A.; Naicker, Dshanta Dyanedi.; Goosen, Mark.; Berrie, Leigh.; Ismail, Arshad.; Garrett, Nigel Joel.; Abdool Karim, Quarraisha.; Abdool Karim, Salim Safurdeen.; Moore, Penny L.; Travers, Simon A.; Morris, Lynn. (American Association of Immunologists., 2015)

Abstract available in pdf.

Acceptability of early antiretroviral therapy among South African women.

Garrett, Nigel Joel.; Norman, Emily.; Leask, Kerry.; Naicker, Nivashnee.; Asari, Villeshni.; Majola, Nelisile.; Abdool Karim, Quarraisha.; Abdool Karim, Salim Safurdeen. (Springer., 2018)

Abstract available in pdf.

Achieving the health Millennium Development Goals for South Africa : challenges and priorities.

Chopra, Mickey.; Lawn, Joy E.; Sanders, David.; Barron, Peter.; Abdool Karim, Salim Safurdeen.; Bradshaw, Debbie.; Jewkes, Rachel.; Abdool Karim, Quarraisha.; Flisher, Alan J.; Mayosi, Bongani M.; Tollman, Stephen M.; Churchyard, Gavin J.; Coovadia, Hoosen Mahomed. (Elsevier., 2009)

15 years after liberation from apartheid, South Africans are facing new challenges for which the highest calibre of leadership, vision, and commitment is needed. The effect of the unprecedented HIV/AIDS epidemic has been ...

Adherence in the CAPRISA 004 tenofovir gel microbicide trial.

Mansoor, Leila Essop.; Abdool Karim, Quarraisha.; Yende-Zuma, Fortunate Nonhlanhla.; MacQueen, Kathleen M.; Baxter, Cheryl.; Madlala, Bernadette T.; Grobler, Anneke.; Abdool Karim, Salim Safurdeen. (Springer., 2014)

High adherence is key to microbicide effectiveness. Here we provide a description of adherence interventions and the adherence rates achieved in the CAPRISA 004 Tenofovir Gel Trial. Adherence support for the before-and-after ...

Adolescent girls and young women: key populations for HIV epidemic control.

Dellar, Rachael C.; Dlamini, Sarah.; Abdool Karim, Quarraisha. (International AIDS Society., 2015)

Abstract available in pdf.

Adolescents and HIV clinical trials: ethics, culture, and context.

MacQueen, Kathleen M.; Abdool Karim, Quarraisha. (Elsevier., 2007)

One quarter of HIV infections globally occur among young people 15-24 years of age and more than half of all new infections are to people younger than 25 years. Clearly, there is a need to identify and implement effective ...

Antibodies for HIV prevention in young women.

Abdool Karim, Salim Safurdeen.; Abdool Karim, Quarraisha.; Baxter, Cheryl. (Wolters Kluwer., 2015)

Abstract available.

Antibody maturation in women who acquire HIV infection while using antiretroviral pre-exposure prophylaxis.

Laeyendecker, Oliver.; Redd, Andrew D.; Nason, Martha.; Longosz, Andrew F.; Abdool Karim, Quarraisha.; Naranbhai, Vivek.; Garrett, Nigel Joel.; Eshleman, Susan H.; Abdool Karim, Salim Safurdeen.; Quinn, Thomas C. (Oxford University Press., 2015)

Abstract available in pdf.

Antiretroviral prophylaxis for HIV prevention reaches a key milestone.

Abdool Karim, Salim Safurdeen.; Abdool Karim, Quarraisha. (Elsevier., 2012)

No abstract available.

Antiretroviral prophylaxis: a defining moment in HIV control.

Abdool Karim, Salim Safurdeen.; Abdool Karim, Quarraisha. (Elsevier., 2011)

No abstract available.

Antiretroviral therapy : challenges and options in South Africa.

Abdool Karim, Salim Safurdeen.; Abdool Karim, Quarraisha.; Baxter, Cheryl. (Elsevier., 2003)

No abstract available.

ARV-based HIV prevention for women Á where are we in 2014.

Mastro, Timothy D.; Sista, Nirupama.; Abdool Karim, Quarraisha. (International AIDS Society., 2014)

Abstract available in pdf.

Assessing adherence in the CAPRISA 004 tenofovir gel HIV prevention trial: results of a nested case–control study.

MacQueen, Kathleen M.; Weaver, Mark A.; van Loggerenberg, Francois.; Succop, Stacey M.; Majola, Nelisile.; Taylor, Douglas.; Abdool Karim, Quarraisha.; Abdool Karim, Salim Safurdeen. (Springer., 2014)

Abstract available in pdf.

Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial.

Mansoor, Leila Essop.; Abdool Karim, Quarraisha.; Mngadi, Kathryn Therese.; Dlamini, Sarah.; Montague, Carl.; Nkomonde, Nelisiwe.; Mvandaba, Nomzamo.; Baxter, Cheryl.; Gengiah, Tanuja Narayansamy.; Samsunder, Natasha.; Dawood, Halima.; Grobler, Anna Christina.; Fröhlich, Janet Ann.; Abdool Karim, Salim Safurdeen. (BioMed Central., 2014)

Background: The Centre for the AIDS Programme of Research in South Africa (CAPRISA) 004 trial demonstrated a 39% reduction in HIV infection, with a 54% HIV reduction in women who used tenofovir gel consistently. A confirmatory ...

Brief report: selection of HIV-1 variants with higher transmission potential by 1% tenofovir gel microbicide.

Ngandu, Nobubelo K.; Carlson, Jonathan M.; Chopera, Denis Rutendo.; Ndabambi, Nonkululeko.; Abdool Karim, Quarraisha.; Abdool Karim, Salim Safurdeen.; Williamson, Carolyn. (Wolters Kluwer Health., 2017)

Abstract available in pdf.

Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women.

Mkhize, Nonhlanhla N.; Durgiah, Raveshni.; Ashley, Vicki C.; Archary, Derseree.; Garrett, Nigel Joel.; Abdool Karim, Quarraisha.; Abdool Karim, Salim Safurdeen.; Moore, Penny L.; Yates, Nicole L.; Passmore, Jo-Ann Shelley.; Tomaras, Georgia D.; Morris, Lynn. (Wolters Kluwer., 2016)

Abstract available in PDF file..

CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck.

Valley-Omar, Ziyaad.; Sibeko, Sengeziwe.; Anderson, Jeffrey A.; Goodier, Sarah A.; Werner, Lise.; Arney, Leslie.; Naranbhai, Vivek.; Treurnicht, Florette K.; Abrahams, Melissa-Rose.; Bandawe, Gama P.; Swanstrom, Ronald.; Abdool Karim, Salim Safurdeen.; Abdool Karim, Quarraisha.; Williamson, Carolyn. (Oxford University Press., 2011)

Alterations of the genital mucosal barrier may influence the number of viruses transmitted from a human immunodeficiency virus–infected source host to the newly infected individual. We used heteroduplex tracking assay and ...

Case 15-2011: A 19-year-old South African woman with headache, fatigue, and vaginal discharge.

Venter, W. D. Francois.; Ndung'u, Peter Thumbi.; Abdool Karim, Quarraisha. (Massachusetts Medical Society., 2011)

No abstract available.

Cervicovaginal inflammation facilitates acquisition of less infectious HIV variants.

Selhorst, Philippe.; Masson, Lindi.; Ismail, Sherazaan D.; Samsunder, Natasha.; Garrett, Nigel Joel.; Mansoor, Leila Essop.; Abdool Karim, Quarraisha.; Abdool Karim, Salim Safurdeen.; Passmore, Jo-Ann Shelley.; Williamson, Carolyn. (Oxford University Press., 2017)

Abstract available in pdf.

Challenges in HIV-prevention microbicide research.

Harrison, Polly.; Mellors, John W.; Richardson, Barbra A.; Masse, Benoit.; Abdool Karim, Quarraisha.; Abdool Karim, Salim Safurdeen.; Cates, Ward.; Coletti, Anne S.; Derbyshire, Janet.; Dorflinger, Laneta J.; Feldblum, Paul J.; Gabelnick, Henry.; Halpern, Vera Grigorieva.; Jespers, Vicky.; Kharsany, Ayesha Bibi Mahomed.; McCormack, Sheena.; Nunn, Andrew.; McGowan, Ian.; Omar, Rabeea F.; Padian, Nancy S.; Pedneault, Louise.; Robbiani, Melissa Pope.; Sailer, James.; Taylor, Douglas.; Tolley, Elizabeth E.; Van Damme, Lut.; Vermund, Sten H.; Van de Wijgert, Janneke. (American Association for the Advancement of Science., 2008)

No abstract available.